GlassScriptPhysician profile
Aracely Alvarez
NPI 1417556721
$5,342.81
in general payments reported to CMS, 2019-2025
44 companies · $480 in 2025
The $480 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,024 · 2022: $1,526 · 2023: $1,226 · 2024: $1,088 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,793.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $706.58 | 2021-2025 | |
| Novo Nordisk INC | $536.65 | 2021-2023 | Rybelsus, Ozempic |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $505.02 | 2021-2025 | Relistor, Xifaxan |
| Amgen INC. | $495.52 | 2021-2024 | Otezla, Repatha, Evenity |
| Astrazeneca Pharmaceuticals LP | $309.49 | 2021-2025 | Airsupra, Breztri, Lokelma |
| Mylan Specialty L.P. | $255.33 | 2021-2024 | Yupelri |
| Sanofi-Aventis U.S. LLC | $246.13 | 2021-2023 | |
| Lilly USA, LLC | $234.33 | 2021-2025 | Mounjaro, Jardiance |
| Exact Sciences Corporation | $219.75 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $173.46 | 2023-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $167.11 | 2021-2024 | Verquvo |
| Indivior INC. | $163.91 | 2021-2025 | Sublocade |
| Bayer Healthcare Pharmaceuticals INC. | $136.62 | 2023-2025 | |
| Xeris Pharmaceuticals, INC. | $134.58 | 2023-2025 | Gvoke Hypopen, Recorlev |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $96.17 | 2022 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aracely Alvarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.